Strategy& Insider Titelbild

Strategy& Insider

Strategy& Insider

Von: Thomas Solbach Ghioia Irritier Jan-Philipp Loch
Jetzt kostenlos hören, ohne Abo

The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter. The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible. Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.PwC Strategy& (Germany) GmbH Hygiene & gesundes Leben Management & Leadership Ökonomie
Folgen
  • Strategy& Insider Episode 50 - Empowering an AI-enabled clinician

    Strategy& Insider Episode 50 - Empowering an AI-enabled clinician
    Sep 23 2026
    Dr. Ami Bhatt, Chief Medical Officer at WHOOP and inaugural chair of the U.S. FDA's Digital Health Advisory Committee, joins the show for the 50th anniversary episode to explore how AI, wearable technology, and equity-first design are transforming healthcare. From the "AI-enabled clinician" to closing gender gaps in heart health and rethinking regulation as scaffolding for innovation rather than a barrier, this episode offers a compelling vision for a smarter, more human healthcare system. Discover why cardiac health is the ultimate longevity hack and how earlier detection is revolutionizing patient outcomes. Learn more about the Strategy& Insider Podcast: https://www.strategyand.pwc.com/de/en/insider-podcast.html Explore our latest healthcare and digital transformation insights: https://www.strategyand.pwc.com/de/en/industries/pharma-life-sciences.html
    Mehr anzeigen Weniger anzeigen
    47 Min.
  • Strategy& Insider Episode 49 - Reinventing the hospital with AI and robotics

    Strategy& Insider Episode 49 - Reinventing the hospital with AI and robotics
    Aug 26 2026
    Dr. Jorge Short Apellániz, Manager of the Rey Juan Carlos University Hospital which is part of Quirónsalud, one of Europe's leading hospital networks, explains how AI, robotics, and digital platforms can fundamentally reshape how care is delivered. Recorded in Madrid at University Hospital Rey Juan Carlos, this episode explores why the future of healthcare is not about technology alone but about connecting care across the entire patient journey – before, during, and after treatment. Jorge shares practical examples of innovation in action: from an AI tool that frees doctors from typing notes to robotic surgery that shortens recovery times, to a patient app used by nearly 9.4 million people. A trained physician turned digital leader, Jorge makes the case that digitalization is the catalyst for a much-needed cultural change in healthcare.
    Mehr anzeigen Weniger anzeigen
    41 Min.
  • Strategy& Insider Episode 48 - Rewriting medicine with CRISPR and genome editing

    Strategy& Insider Episode 48 - Rewriting medicine with CRISPR and genome editing
    Jul 22 2026
    What if curing a disease took a single treatment instead of a lifetime of pills, and the same technology could help cool the planet? In this episode, Dr. Bradley Ringeisen, Executive Director of the Innovative Genomics Institute (IGI) at UC Berkeley, takes us inside the CRISPR revolution. From the first FDA-approved sickle cell therapy to a custom cure that saved a baby's life in Philadelphia, to rice engineered to emit 60% less methane, Brad reveals how genome editing is reshaping medicine, climate, and food security alike. We dig into the science, the make-or-break "delivery" challenge, and the IGI's "CRISPR Commons" initiative, a bold plan to make genome editing equitably accessible worldwide.
    Mehr anzeigen Weniger anzeigen
    42 Min.
adbl_web_anon_alc_button_suppression_t1
Noch keine Rezensionen vorhanden